Drug Profile
Research programme: schizophrenia therapeutic - Daewoong Pharmaceutical
Alternative Names: IMD4; Incrementally modified drug 4Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Schizophrenia in South Korea